Association Between Serum Lipids and Survival in Patients With Amyotrophic Lateral Sclerosis
A Meta-analysis and Population-Based Study
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received March 3, 2022
- Accepted in final form October 20, 2022
- First Published December 2, 2022.
Article Versions
- Previous version (December 2, 2022 - 12:45).
- You are viewing the most recent version of this article.
Author Disclosures
- Mark R. Janse van Mantgem, MD,
- Wouter van Rheenen, MD, PhD,
- Anemone V. Hackeng, BSc,
- Michael A. van Es, MD, PhD,
- Jan H. Veldink, MD, PhD,
- Leonard H. van den Berg, MD, PhD* and
- Ruben P.A. van Eijk, MD, PhD*
- Mark R. Janse van Mantgem, MD,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Wouter van Rheenen, MD, PhD,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Sponsored research agreement with Biogen
(1) Dutch Research Council (NWO) [VENI scheme grant <br>09150161810018]
NONE
(1) Prinses Beatrix Spierfonds (neuromuscular fellowship <br>grant W.F19-03).
NONE
NONE
NONE
NONE
NONE
NONE
- Anemone V. Hackeng, BSc,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Michael A. van Es, MD, PhD,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Jan H. Veldink, MD, PhD,
None
NONE
Invited speaker at Biogen Inc. in Boston (US) in 2019
NONE
NONE
NONE
NONE
Biogen Inc.<br><br>Astra Zeneca
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Leonard H. van den Berg, MD, PhD* and
Scientific Advisory Boards of Amylyx, Ferrer, Biogen, Cytokinetics
NONE
Takeda
Amyotrophic Lateral Sclerosis and Frontotemporal <br><br><br><br>Degeneration<br><br><br><br>Neuromuscular Disorders
NONE
NONE
NONE
NONE
NONE
received an educational grant from Takeda
NONE
NONE
NONE
NONE
Netherlands ALS Foundation
NONE
NONE
NONE
NONE
NONE
NONE
- Ruben P.A. van Eijk, MD, PhD*
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- From the Department of Neurology (M.R.J.M., W.R., A.V.H., M.A.E., J.H.V., L.H.B., R.P.A.E.), UMC Utrecht Brain Center, and Biostatistics & Research Support (R.P.A.E.), Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, The Netherlands.
- Correspondence
Dr. van den Berg lberg{at}umcutrecht.nl
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. David E. Vaillancourt and Dr. Shannon Y. Chiu
► Watch
Related Articles
- No related articles found.